<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="47962">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02481817</url>
  </required_header>
  <id_info>
    <org_study_id>150917</org_study_id>
    <nct_id>NCT02481817</nct_id>
  </id_info>
  <brief_title>Treatment Alternatives in iSGS (NoAAC PR-02 Study)</brief_title>
  <acronym>NoAAC PR-02</acronym>
  <official_title>Treatment Alternatives in Adult Rare Disease; Assessment of Options in Idiopathic Subglottic Stenosis North American Airway Collaborative PR-02 Study (NoAAC PR-02 Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Patient-Centered Outcomes Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Utah</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Vanderbilt University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Virginia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Massachusetts Eye and Ear Infirmary</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Oregon Health and Science University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Washington</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of California, Los Angeles</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of California, San Diego</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Baylor College of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Louisiana State University Health Sciences Center in New Orleans</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Charing Cross Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Alabama at Birmingham</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Wisconsin, Madison</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Nebraska</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Iowa</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Texas</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of North Carolina</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Augusta University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Sydney</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>North American Airway Collaborative</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of California, Irvine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Loma Linda University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Cincinnati</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Emory University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ohio State University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Southern California</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Temple University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medical College of Wisconsin</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Landspitali University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bastian Voice Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>New York University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Miami</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Vanderbilt University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is aimed at answering the questions; (1) How well do the most commonly used
      treatments in iSGS work? and (2) What quality-of-life trade-offs are associated with each
      approach?

      With the results of this trial, the investigators hope to provide information to iSGS
      patients: (1) Given my personal characteristics, conditions, and preferences, what should I
      expect will happen to me? and (2) What are my options, and what are the potential benefits
      and harms of these options?
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Idiopathic subglottic stenosis (iSGS) is a rare disease in which the trachea narrows for no
      known reason. Although uncommon (with an estimated incidence of 1:400,000 persons per year),
      both the disease and its therapies profoundly affect patients' ability to breathe,
      communicate and swallow. Breathing difficulties (i.e. dyspnea) is the hallmark symptom and
      the primary cause of death and disability. However, patients can also experience
      debilitating voice changes and swallowing problems due to the condition or its treatment.

      People with this disease often require several surgeries per year. A variety of treatments
      have been advanced to manage iSGS but are generally categorized into: 1) endoscopic dilation
      of the tracheal stenosis (accomplished with rigid instruments or inflatable balloons); 2)
      endoscopic resection of the stenosis (with prolonged medical therapy after surgery); or 3)
      open neck surgery with resection of the affected tracheal segment with end-to-end
      anastomosis. Each patient can require repeated surgeries to keep their trachea open, which
      increases odds of treatment side effects and complications. All approaches have unique and
      often disabling associated side effects, which can significantly affect a patient's quality
      of life.

      Because the disease is rare, it is difficult for patients to find good information so that
      they can understand the spectrum of treatment options. This is particularly difficult
      because most patients present with severe breathing trouble and need treatment quickly,
      limiting their ability to explore options. Additionally, there is a general lack of
      high-quality, reliable, and accessible data to inform individual patient decision-making.
      Imperfect information and limited evidence on treatment outcomes complicate patient
      decision-making as they try to balance survival, symptoms, and quality of life
      considerations.

      Beyond the gaps in understanding the relative effectiveness of the different treatments
      available, no studies have explored functional outcomes in iSGS (i.e. how well patients
      breathe, speak, and swallow after treatments). These endpoints are important to patients and
      are arguably a primary determinant in decision-making. Direct engagement with patients is
      critical to understand these quality of life considerations, since patient and physician
      perspectives aren't always the same. For example, results show that endoscopic dilation is
      associated with a higher rate of disease recurrence and thus need for repeated surgery.
      Meanwhile, open tracheal resection is a major surgery with significant immediate
      perioperative risks and has been associated with alterations in voice and swallowing. Open
      tracheal resection appears to reduce the risk of disease recurrence, but the degree of
      benefit, and the trade-offs associated with this approach are unanswered questions.

      The proposed study from the North American Airway Collaborative (NoAAC PR- 02) is designed
      to fill this void. Our prospective study will directly compare the effectiveness of standard
      of care treatments and assess their associated quality of life tradeoffs in iSGS patients.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 28, 2015</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Treatment Effectiveness: Time to recurrent procedure</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Treatment Effectiveness: Need for tracheostomy</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>QOL</measure>
    <time_frame>3 years</time_frame>
    <description>Patient quality of life assessment: voice (VHI-10)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>QOL</measure>
    <time_frame>3 years</time_frame>
    <description>Patient quality of life assessment: dysphagia (EAT-10)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>QOL</measure>
    <time_frame>3 years</time_frame>
    <description>Patient quality of life assessment: breathing (COPD dyspnea)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>QOL</measure>
    <time_frame>3 years</time_frame>
    <description>Patient quality of life assessment: general quality of life (SF-12)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Reported Outcome</measure>
    <time_frame>3 years</time_frame>
    <description>Non-traditional PRO focused on social support</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Reported Outcome</measure>
    <time_frame>3 years</time_frame>
    <description>Non-traditional PRO focused on fear of disease recurrence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Reported Outcome</measure>
    <time_frame>3 years</time_frame>
    <description>Non-traditional PRO focused on disease anxiety and burden</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Reported Outcome</measure>
    <time_frame>3 years</time_frame>
    <description>Non-traditional PRO focused on participatory decision-making style</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Idiopathic Subglottic Stenosis (iSGS)</condition>
  <arm_group>
    <arm_group_label>iSGS patients</arm_group_label>
    <description>Participants will receive standard of care treatment at the respective center and will be followed longitudinally for symptom changes, need for further treatment, complications, and will have Patient-reported outcomes (PROs) administered at a priori determined intervals.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endoscopic dilation of subglottic stenosis</intervention_name>
    <description>This is accomplished with rigid instruments or inflatable balloons.</description>
    <arm_group_label>iSGS patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endoscopic resection of the stenosis</intervention_name>
    <description>This is accomplished with C02 lasers and paired with prolonged medical therapy after surgery.</description>
    <arm_group_label>iSGS patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Tracheal Resection</intervention_name>
    <description>Resection of the affected tracheal segment with end-to-end anastomosis</description>
    <arm_group_label>iSGS patients</arm_group_label>
    <other_name>Cricotracheal Resection</other_name>
    <other_name>Open Airway Surgery</other_name>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Biospecimens collected during routine standard of care from each patient (such as tracheal
      biopsies obtained during surgery, or surgical specimens generated thru open reconstructive
      surgeries), will be annotated in the EDC with such data including specimen collection,
      specimen type (e.g., frozen biopsy tissue; FFPE block), and storage location. We may examine
      excess tissue obtained at standard of care surgical biopsy. Additionally if blood is
      collected during standard of care (i.e., medically indicated labs, operative or office-based
      procedures), we will ask participants to provide a one-time, 30 mL blood specimen for
      research.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All clinically confirmed iSGS patients at the participating institutions are eligible for
        enrollment.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Greater than 18 years of age.

          -  The lesion must involve the subglottis.

        Exclusion Criteria:

          -  Less than 18 years of age

          -  Patients without capacity to consent for themselves

          -  History of significant laryngotracheal traumatic injury.

          -  History of endotracheal intubation or tracheotomy within 2 years of presentation.

          -  Major anterior neck surgery.

          -  History of neck irradiation.

          -  History of caustic or thermal injuries to the laryngotracheal complex.

          -  History of a clinically diagnosed vasculitis or collage vascular disease.

          -  Positive antinuclear cytoplasmic antibody titers.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexander Gelbard, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt University Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David O. Francis, MD, MS</last_name>
    <role>Study Chair</role>
    <affiliation>Vanderbilt University Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Cheryl Kinnard, RN</last_name>
    <phone>615-322-0333</phone>
    <email>cheryl.kinnard@Vanderbilt.Edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kate Von Wahlde, MJ, CCRP</last_name>
    <phone>615-322-0333</phone>
    <email>kate.vonwahlde@Vanderbilt.Edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35233</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amalee Smith</last_name>
      <phone>205-934-9766</phone>
      <email>amaleesmith@uabmc.edu</email>
    </contact>
    <investigator>
      <last_name>Paul F. Castellanos, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85054</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joy Few</last_name>
      <phone>480-342-2131</phone>
    </contact>
    <investigator>
      <last_name>David G. Lott, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California Irvine</name>
      <address>
        <city>Irvine</city>
        <state>California</state>
        <zip>92606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <phone>949-225-6300</phone>
    </contact>
    <investigator>
      <last_name>Sunil Verma, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Loma Linda University Health Care</name>
      <address>
        <city>Loma Linda</city>
        <state>California</state>
        <zip>92354</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>909-558-2822</phone>
    </contact>
    <investigator>
      <last_name>Brianna K Crawley, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Southern California</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>323-226-2622</phone>
    </contact>
    <investigator>
      <last_name>Lindsay Reder, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California Los Angeles</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <phone>310-206-6688</phone>
    </contact>
    <investigator>
      <last_name>Dinesh Chhetri, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <phone>650-723-5281</phone>
    </contact>
    <investigator>
      <last_name>Edward Damrose, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kwang Sung, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>858-657-8590</phone>
    </contact>
    <investigator>
      <last_name>Philip Weissbrod, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Samir Makani, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <phone>415-885-7700</phone>
    </contact>
    <investigator>
      <last_name>Mark Courey, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Colorado</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kristi Engle Folchert, MA, CCRP</last_name>
      <phone>303-724-1950</phone>
    </contact>
    <investigator>
      <last_name>Matthew S. Clary, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <phone>305-243-5290</phone>
    </contact>
    <investigator>
      <last_name>David E Rosow, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emory University School of Medicine</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <phone>404-727-6123</phone>
    </contact>
    <investigator>
      <last_name>Craig Villari, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Augusta University</name>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <zip>30912</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sherif Shaaban</last_name>
      <phone>706-721-6100</phone>
      <email>SSHAABAN@gru.edu</email>
    </contact>
    <investigator>
      <last_name>Gregory Postma, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bastian Voice Institute</name>
      <address>
        <city>Downers Grove</city>
        <state>Illinois</state>
        <zip>60515</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <phone>630-724-1100</phone>
    </contact>
    <investigator>
      <last_name>Brent Richardson, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Iowa</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kimberly Sprenger, RN</last_name>
      <phone>800-777-8442</phone>
      <email>kimberly-sprenger@uiowa.edu</email>
    </contact>
    <investigator>
      <last_name>Douglas J Van Daele, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Henry Hoffman, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Louisiana State University</name>
      <address>
        <city>Baton Rouge</city>
        <state>Louisiana</state>
        <zip>70809</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Belle Ton, RN</last_name>
      <phone>225-765-5335</phone>
    </contact>
    <investigator>
      <last_name>Andrew J. McWhorter, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dan Fink, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>443-997-6467</phone>
    </contact>
    <investigator>
      <last_name>Alexander T. Hillel, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Harvard Medical School -Massachusetts Eye and Ear Infirmary</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <phone>617-573-3958</phone>
    </contact>
    <investigator>
      <last_name>Ramon Franco, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Toni Melendez, MSW</last_name>
      <phone>734-764-3501</phone>
    </contact>
    <investigator>
      <last_name>Robbi Kupfer, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Norman Hogikyan, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55902</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Danielle Fogelson, RN</last_name>
      <phone>507-284-3578</phone>
      <email>Fogelson.Danielle@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Jan L. Kasperbauer, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dale C. Ekbom, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eric S. Edell, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Nebraska</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68198</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <phone>402-559-5208</phone>
    </contact>
    <investigator>
      <last_name>Christopher M. Bingcang, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Estelle Chang, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>New York University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <phone>212-263-3705</phone>
    </contact>
    <investigator>
      <last_name>Milan Amin, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of North Carolina</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>984-974-6484</phone>
    </contact>
    <investigator>
      <last_name>Rupali N. Shah, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Robert Buckmire, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Duke University</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy Walker</last_name>
      <phone>919-681-7350</phone>
      <email>amy.walker1@duke.edu</email>
    </contact>
    <investigator>
      <last_name>Seth Cohen, M.D., M.P.H.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Cincinatti</name>
      <address>
        <city>Cincinatti</city>
        <state>Ohio</state>
        <zip>45267</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Becky Reinert, CCRP</last_name>
      <phone>513-558-1719</phone>
      <email>gibsonrk@ucmail.uc.edu</email>
    </contact>
    <investigator>
      <last_name>Rebecca Howell, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Christine Fleckenstein</last_name>
      <phone>216-444-3104</phone>
      <email>FLECKEC@ccf.org</email>
    </contact>
    <investigator>
      <last_name>Robert R. Lorenz, M.D., MBA</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paul C. Bryson, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael S. Benninger, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Ohio State University Wexner Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beth Miles-Markley, MS, CCRP</last_name>
      <phone>614-366-3687</phone>
      <email>Beth.Miles-Markley@osumc.edu</email>
    </contact>
    <investigator>
      <last_name>Laura Matrka, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oregon Health &amp; Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <phone>503-494-5947</phone>
    </contact>
    <investigator>
      <last_name>Joshua S. Schindler, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Temple University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19140</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>215-885-4840</phone>
    </contact>
    <investigator>
      <last_name>Ahmed Soliman, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>412-647-8762</phone>
    </contact>
    <investigator>
      <last_name>Clark Rosen, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cheryl Kinnard, RN</last_name>
      <phone>615-322-0333</phone>
      <email>cheryl.kinnard@Vanderbilt.Edu</email>
    </contact>
    <contact_backup>
      <last_name>Kate Von Wahlde, MJHL</last_name>
      <phone>615-322-0333</phone>
      <email>kate.vonwahlde@vanderbilt.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Alexander Gelbard, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Francis, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christopher Wootten, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>C. Gaelyn Garrett, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>James Netterville, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Otis Rickman, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <phone>214-645-8898</phone>
    </contact>
    <investigator>
      <last_name>Ted Mau, M.D., Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baylor College of Medicine</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacqueline Childs</last_name>
      <phone>713-798-5906</phone>
    </contact>
    <investigator>
      <last_name>Julina Ongkasuwan, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Donald Donovan, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrew Sikora, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ken Altman, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>801-581-7514</phone>
    </contact>
    <investigator>
      <last_name>Marshal E. Smith, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Virginia</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908-0713</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>434-924-5700</phone>
    </contact>
    <investigator>
      <last_name>James J. Daniero, M.D., M.S.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Washington</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>206-543-5230</phone>
    </contact>
    <investigator>
      <last_name>Albert Merati, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Wisconsin</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53792</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heather M Geye, M.S.</last_name>
      <phone>608-265-6260</phone>
      <email>geye@humonc.wisc.edu</email>
    </contact>
    <investigator>
      <last_name>Seth H. Dailey, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical College of Wisconsin</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>414-805-3666</phone>
    </contact>
    <investigator>
      <last_name>Joel Blumin, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jonathan Bock, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Sydney</name>
      <address>
        <city>St Leonards</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paula McLeod</last_name>
      <phone>02-9463-1207</phone>
      <email>daveveivers@iprimus.com.au</email>
    </contact>
    <investigator>
      <last_name>David Veivers, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Landspitali University Hospital</name>
      <address>
        <city>Reykjavik</city>
        <zip>101-155</zip>
        <country>Iceland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+ 354-824-5469</phone>
    </contact>
    <investigator>
      <last_name>Sigríður Sveinsdóttir, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Charing Cross Hospital, Imperial College London</name>
      <address>
        <city>London</city>
        <zip>W6 8RF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Margaret Ashcroft</last_name>
      <phone>020 3311 1234</phone>
      <email>RN@cantab.net</email>
    </contact>
    <investigator>
      <last_name>Guri Sandhu, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>S.A.R. Nouraei, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Iceland</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 13, 2017</lastchanged_date>
  <firstreceived_date>June 22, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University Medical Center</investigator_affiliation>
    <investigator_full_name>Alexander Gelbard, MD</investigator_full_name>
    <investigator_title>Assistant Professor, Department of Otolaryngology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Constriction, Pathologic</mesh_term>
    <mesh_term>Laryngostenosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
